Satisfaction and Quality of Life in Patients With a Diagnosis of DVT (Deep Venous Thrombosis) Who Take Rivaroxaban
Phase of Trial: Phase IV
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism
- Focus Therapeutic Use
- Acronyms SATORI
- Sponsors Bayer
- 13 Nov 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 09 Oct 2015 Planned end date changed from 1 Sep 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.
- 13 Apr 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.